National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN) is a public charity based in Plymouth Meeting, Pennsylvania, and an alliance of 34 leading cancer centers devoted to patient care, research, and education. Founded in 1993, it works to advance cancer care and prevention and makes grants, including research grants to cancer centers and academic institutions.
National Comprehensive Cancer Network at a glance
In short: National Comprehensive Cancer Network gave $2.8M across 26 grants in 2024 (avg $108K), top state Massachusetts. 12% of 2024 grantees were new. Source: 2024 IRS Form 990.
- Annual giving (2024)
- $2,818,537
- +24.7% vs 2023
- Grants made (2024)
- 26
- +13.0% vs 2023
- Average grant
- $108,405
- +10.3% vs 2023
- Median grant
- $78,181
- Total assets
- $172,948,425
- +13.1% vs 2023
- New grantees (estimate)
- 12% first-time grantees (3 of 26, 2024)
- Primary geography
- Massachusetts (28% of itemized 2024 grant dollars)
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated October 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to National Comprehensive Cancer Network
- How to Apply
-
For active ORP requests for proposals, proposals and letters of intent must be submitted through the NCCN ORP website. Applicants follow the instructions and requirements in the applicable request for proposals, use the submission portal, and provide the requested forms, templates, and supporting documentation. The submission manual advises new account holders to use their NCCN Member Institution email address.
- Contact
Mailing address: 3025 Chemical Road 100, Plymouth Meeting, PA 19462
Phone: (215) 690-0300
Website: https://nccn.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Who National Comprehensive Cancer Network funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
The largest 2024 recipient was Mass General Hospital ($573K). Together the top 10 received $2.0M.
Grant Size Distribution
122 grants across all recorded years
The most common grant size was under $50K: 41 grants of 122 (34%).
Geographic Focus
Where this funder awards grants
In 2024, the largest shares of grant dollars went to recipients in Massachusetts (28%), Pennsylvania (13%), Ohio (12%), New York (11%), and Minnesota (6%). The listed grants also include recipients in other states.
Grant Distribution by State
Share of 2024 grant dollars across all 26 itemized grants.
States
Cities
Is National Comprehensive Cancer Network open to new grantees?
12%
first-time grantees, 2024
In 2024, 3 of 26 grantees (12%) were first-time recipients. First grants averaged $101K; repeat grants $109K. How we count
Medians: $90K first-time, $77K repeat.
Estimate from itemized grant lists in IRS Form 990 filings (2020–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $1.8M (2021) to $3.4M (2020). In 2024 it made 26 grants totaling $2.8M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Mass General Hospital Boston, MA | Research | $573,487 |
| Health Research Inc Buffalo, NY | Research | $261,184 |
| Dana Farber Cancer Institute Boston, MA | Research | $207,500 |
| The Ohio State University Comprehensive Cancer Center Columbus, OH | Research | $160,000 |
| Institute for Cancer Research Cheltenham, PA | Research | $157,871 |
| Mayo Clinic Rochester, MN | Research | $156,232 |
| Uh Seidman Cancer Center Cleveland, OH | Research | $137,500 |
| The Trustees of the U of Penn Philadelphia, PA | Research | $124,882 |
| Vanderbilt University Medical Center Atlanta, GA | Research | $114,250 |
| Johns Hopkins University Baltimore, MD | Research | $93,518 |
Ready to take the next step with National Comprehensive Cancer Network?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $172,948,425 | $55,716,889 | $43,512,983 | $2,818,537 | 26 | $4,909,013 |
| 2023 | $152,900,973 | $53,802,849 | $39,912,035 | $2,260,339 | 23 | $3,911,937 |
| 2022 | $133,378,564 | $52,064,807 | $36,027,525 | $1,870,432 | 24 | $1,791,586 |
| 2021 | $114,912,916 | $46,211,501 | $30,230,411 | $1,813,119 | 22 | $1,382,823 |
| 2020 | $95,474,983 | $45,608,830 | $31,957,857 | $3,446,540 | 27 | $1,043,214 |
Research compiled by Grantable AI from public sources. Last updated October 2026.
Mission & Focus Areas
NCCN’s mission is to define and advance quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. Its stated programs include clinical practice guidelines and educational programs, patient information and care-quality measures, public and professional information to facilitate access to cancer specialty services, and development of a clinical research network.
Through its Oncology Research Program (ORP), NCCN supports research and quality-improvement collaborations. The program’s stated aims include studying approved and investigational cancer agents and devices, examining cancer-care delivery outcomes and quality, and supporting research by faculty at NCCN Member Institutions. Its brochure describes investigator-initiated research grants, quality-improvement collaborations, and protocol development with industry collaborators.
The 2024 grants include research awards to cancer centers and universities. Among the grantees described in the supplied information, Dana-Farber Mass General Brigham Cancer Care said its mission includes coordinating oncology research, education, and programs across Dana-Farber, Massachusetts General Hospital, and Brigham and Women’s Hospital. Fox Chase Cancer Center Foundation described its mission as pursuing scientific discovery, prevention, and compassionate care. Mayo Clinic described its mission as providing patient care through integrated clinical practice, education, and research.
Grantmaking
In filing year 2024, NCCN reported 26 grants totaling $2,818,537. Grant amounts ranged from $5,375 to $573,487, with a median of $78,181. The largest listed grants were for research and went to Mass General Hospital ($573,487), Health Research Inc ($261,184), Dana-Farber Cancer Institute ($207,500), The Ohio State University Comprehensive Cancer Center ($160,000), Institute for Cancer Research ($157,871), and Mayo Clinic ($156,232).
Other notable 2024 recipients included UH Seidman Cancer Center ($137,500), the Trustees of the University of Pennsylvania ($124,882), Vanderbilt University Medical Center ($114,250), Johns Hopkins University ($93,518), Duke University ($89,957), and Fox Chase Cancer Center ($82,760). In the grantee’s own description, the Trustees of the University of Pennsylvania said the university aims to advance research and provide high-quality patient care; Johns Hopkins University described its work as including extensive research across multiple disciplines.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2024 filing listed Matt Kalaycio, MD, as director and vice-chair; Patrick J. O’Brien, MBA, as director and treasurer; and Maria M. Gonzalez, MPH, BS, as secretary. It also listed Robert H. Vonderheide, MD, DPhil; Ravi Salgia, MD, PhD; Craig A. Bunnell, MD, MBA, MPH; Edwin P. Alyea III, MD; Julie M. Vose, MD, MBA; Nancy E. Davidson, MD; and Philippe E. Spiess, MD, MS, FACS, FRC, as directors. NCCN’s website identifies Crystal S. Denlinger, MD, as chief executive officer.
National Comprehensive Cancer Network is led by Crystal Delinger MD, Chief Executive Officer since 2023 (on filings since 2021); 10 of 46 officers listed in 2024 are compensated.
Officers on the 2024 filing
Crystal Delinger MD
Chief Executive Officer
Chief Scientific Officer → Chief Executive Officer, 2023
On filings since 2021
40 hrs/week
$222K (2021) → $679K (2024)
Patrick Delaney
Executive Director - Nccn Foundation
New on the 2024 filing
4 hrs/week
$221K (2024)
Evelyn Handel
Senior Director, Drugs & B
Director, Drugs & Biologics Program → Senior Director, Drugs & Biologics Programs, 2023
Senior Director, Drugs & Biologics Programs → Senior Director, Drugs & B, 2024
On filings since 2020
40 hrs/week
$173K (2020) → $210K (2024)
Joseph Junod
Senior Director
On filings since 2021
40 hrs/week
$173K (2021) → $215K (2024)
Al B. Benson Iii Md Facp Fasco
Director
On filings since 2020
2 hrs/week
No compensation reported
Alan P. Venook MD
Director
On filings since 2020
2 hrs/week
No compensation reported
Alberto S. Pappo MD
Director
On filings since 2020
2 hrs/week
No compensation reported
Craig A. Bunnell MD MBA MPH
Director
On filings since 2020
2 hrs/week
No compensation reported
David G. Pfister MD
Director
On filings since 2020
2 hrs/week
No compensation reported
Laura W. Goff Md Mmhc Msci
Director
On filings since 2020
2 hrs/week
No compensation reported
Lisle M. Nabell MD
Director
On filings since 2020
2 hrs/week
No compensation reported
Nancy E. Davidson MD
Director
On filings since 2020
2 hrs/week
No compensation reported
Patrick J. O'Brien MBA
Director & Treasurer
On filings since 2020
2 hrs/week
No compensation reported
Ravi Salgia MD PhD
Director
On filings since 2020
2 hrs/week
No compensation reported
Robert H. Vonderheide Md Dphil
Director
On filings since 2020
2 hrs/week
No compensation reported
Stephen B. Edge Md Facs Fasco
Director
On filings since 2020
2 hrs/week
No compensation reported
Steven J. Frank MD
Director
On filings since 2020
2 hrs/week
No compensation reported
Timothy J. Eberlein MD
Director
On filings since 2020
2 hrs/week
No compensation reported
William E. Carson III MD
Director
On filings since 2020
2 hrs/week
No compensation reported
Elizabeth R. Plimack Md Ms
Director
On filings since 2021
2 hrs/week
No compensation reported
Lee G. Wilke Md Facs
Director
On filings since 2021
2 hrs/week
No compensation reported
Richard D. Schulick Md Mba Facs
Director
On filings since 2021
2 hrs/week
No compensation reported
Rondeep Brar MD
Director
On filings since 2021
2 hrs/week
No compensation reported
Sachin M. Apte Md Mba Ms
Director
On filings since 2021
2 hrs/week
No compensation reported
Kevin P. Lee MD
Director
On filings since 2022
2 hrs/week
No compensation reported
Matt Kalaycio MD
Director & Vice Chair
On filings since 2022
2 hrs/week
No compensation reported
Timothy R. Donahue MD
Director
On filings since 2022
2 hrs/week
No compensation reported
David T. Cooke Md Facs
Director
On filings since 2023
2 hrs/week
No compensation reported
Edwin P. Alyea III MD
Director
On filings since 2023
2 hrs/week
No compensation reported
Mitchell C. Posner Md Facs
Director
On filings since 2023
2 hrs/week
No compensation reported
Philippe E. Spiess Md Ms Facs Frc
Director
On filings since 2023
2 hrs/week
No compensation reported
Amy E. Dezern Md Mhs
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Bryan J. Schneider MD
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Carlos L. Arteaga MD
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Diane Simeone MD
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Eric P. Winer MD
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Julie M. Vose MD MBA
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Robert R. McWilliams Md Msc Msha
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Eileen Boscia
Chief Financial Officer
On filings since 2020
40 hrs/week
$263K (2020) → $360K (2024)
Gary Weyhmuller
Chief Operating Officer
On filings since 2020
40 hrs/week
$533K (2020) → $629K (2024)
Jennifer Tredwell
Senior Vice President, Marketing & Com
Vice President, Marketing & Communications → Senior Vice President, Marketing & Communications, 2023
Senior Vice President, Marketing & Communications → Senior Vice President, Marketing & Com, 2024
On filings since 2020
40 hrs/week
$186K (2020) → $245K (2024)
Kristina M. Gregory
Senior Vice President & Clinical Inform
Vice President & Clinical Information P → Senior Vice President & Clinical Information P, 2023
Senior Vice President & Clinical Information P → Senior Vice President & Clinical Inform, 2024
On filings since 2020
40 hrs/week
$299K (2020) → $375K (2024)
Wui-Jin Koh MD
Chief Medical Officer
On filings since 2020
40 hrs/week
$535K (2020) → $614K (2024)
Beth Gaffney
Vice President - Us & Global Business
Vice President - Us & Global Business Development → Vice President - Us & Global Business, 2022
On filings since 2021
40 hrs/week
$222K (2021) → $282K (2024)
Christopher H. Lieu MD
Vice Chair
Director → Vice Chair, 2024
On filings since 2020
2 hrs/week
No compensation reported
Maria M. Gonzalez Mph Bs
Secretary
Director → Secretary, 2024
On filings since 2023
2 hrs/week
No compensation reported
Former officers (51)
- Former: David S. Ettinger Md Facp Fccp (2020–2023) — Director
- Former: Joseph A. Califano III MD (2020–2023) — Director
- Former: Kenneth H. Cowan MD PhD (2020–2023) — Director
- Former: Lori C. Pickens Mha (2020–2023) — Director
- Former: Robert R. McWilliams Md Msc (2020–2023) — Director
- Former: Robert W. Carlson MD (2020–2023) — Chief Executive Officer - Former
- Former: Ronald S. Walters Md Mba Mha Ms (2020–2023) — Director
- Former: Samuel M. Silver Md Phd Macp (2020–2023) — Director
- Former: Theodoros Teknos MD (2020–2023) — Director
- Former: Rebecca L. Caires MBA (2021–2023) — Director
- Former: Robin Famiglietti Phd Mba Fache (2022–2023) — Director
- Former: Ashley B. Lee (2023) — Director
- Former: Ayad Hamdan MD (2023) — Director
- Former: Barbara A. Jagels Rn Mha Cphq (2023) — Director
- Former: Brittany McCreery MD MBA (2023) — Director
- Former: Christina J. Longnecker Bsn MBA JD (2023) — Director
- Former: Cynthia McCollum MBA (2023) — Director
- Former: David B. Miller MBA (2023) — Director
- Former: David C. Smith MD (2023) — Director
- Former: David Shibata Md Facs Fascrs (2023) — Director
- Former: Donald F. Milligan MBA (2023) — Director
- Former: Donna Powell (2023) — Manager, Radiation Therapy & Imaging Programs
- Former: Elizabeth A. Souza Mha (2023) — Director
- Former: Gena Cook (2023) — Director
- Former: Gina Dayton Mpa (2023) — Director
- Former: James E. Bachman Mpa (2023) — Director
- Former: John W. Sweetenham Md Facp Fasco (2023) — Director & Chair
- Former: Jolene Summer Bolster (2023) — Director
- Former: Jordan M. Demoss Msha (2023) — Director
- Former: Katie McGill Msm (2023) — Director
- Former: Kris M. Kipp Msn RN (2023) — Director
- Former: Kyle A. Taylor Mhsa Cphq (2023) — Director
- Former: Kyle F. Skiermont Pharmd (2023) — Director
- Former: Laurel Bray-Hanin Ma (2023) — Director
- Former: Lauren Wall Ms (2023) — Director
- Former: Michael R. Kuettel MD PhD MBA (2023) — Director
- Former: Peter Connor Ms (2023) — Director
- Former: Theresa Sberna MPH (2023) — Director
- Former: Yvette Tremonti CPA MBA (2023) — Director
- Former: John W. Sweetenham Md Facp Frcp (2020–2022) — Director & Chair
- Former: Linda Leach (2020–2022) — Vice President, Administrator & Human Resourc
- Former: Louis B. Harrison MD (2020–2022) — Director
- Former: Richard Bold MD MBA (2021–2022) — Director
- Former: Michael L. Steinberg MD (2020–2021) — Director
- Former: Thomas A. D'amico MD (2020–2021) — Director
- Former: C. Lyn Fitzgerald (2020) — Former - Senior Vice President, Us & Global Development
- Former: Eben L. Rosenthal MD (2020) — Director
- Former: Richard I. Fisher MD (2020) — Director
- Former: Ruth M. O'Regan MD (2020) — Director & Vice Chair
- Former: Susan Most (2020) — Senior Director & Clinical Operations
- Former: Thomas K. Varghese Jr Md Ms Facs (2020) — Director
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $679K, to Crystal Delinger MD (Chief Executive Officer). 10 officers or directors reported compensation on that filing.
Frequently asked questions about National Comprehensive Cancer Network
How much does National Comprehensive Cancer Network give each year?
National Comprehensive Cancer Network gave $2.8M across 26 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $2.3M across 23 grants.
What is National Comprehensive Cancer Network's typical grant size?
National Comprehensive Cancer Network's median grant in 2024 was $78,181, and its average grant was $108,405, across 26 grants on its 2024 IRS Form 990. Organizations receiving their first grant from National Comprehensive Cancer Network that year got $101K on average.
Where does National Comprehensive Cancer Network give grants?
National Comprehensive Cancer Network's top state is Massachusetts, with 28% of the grant dollars itemized on its 2024 IRS Form 990. The next largest states were Pennsylvania (13%) and Ohio (12%). The most frequent recipient cities were Boston, MA (2 grants), Buffalo, NY (2 grants), Philadelphia, PA (2 grants) and Cleveland, OH (2 grants).
Does National Comprehensive Cancer Network give general operating support?
Not in 2024: none of the 26 grants with a stated purpose on National Comprehensive Cancer Network's 2024 IRS Form 990 were described as general or operating support. Recurring purposes include "Research" (26 grants).
Who are National Comprehensive Cancer Network's largest grantees?
National Comprehensive Cancer Network's largest 2024 grantees include Mass General Hospital ($573,487), Health Research Inc ($261,184) and Dana Farber Cancer Institute ($207,500), according to its 2024 IRS Form 990. Together they received 37% of its itemized 2024 grant dollars.
How large is National Comprehensive Cancer Network?
National Comprehensive Cancer Network reported $172.9M in total assets on its 2024 IRS Form 990. Its revenue that year was $55.7M.
What does National Comprehensive Cancer Network fund?
NCCN’s mission is to define and advance quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. See mission & focus areas ↑
How do I apply for a grant from National Comprehensive Cancer Network?
For active ORP requests for proposals, proposals and letters of intent must be submitted through the NCCN ORP website. Eligibility and process details are in the grantmaking section of this profile. See how to apply ↑
What is National Comprehensive Cancer Network's EIN?
National Comprehensive Cancer Network's EIN (Employer Identification Number) is 23-2818395. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS November 10, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS November 8, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS November 14, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS November 15, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS November 3, 2025)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work National Comprehensive Cancer Network funds
Health Open opportunities, soonest deadline first.
Explore Open Grants
Browse active grant opportunities in National Comprehensive Cancer Network's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
American Lung Association
Chicago, IL
The American Lung Association funds research on lung disease, lung cancer, tobacco use, and air quality, primarily through defined research-award programs for investigators at eligible U.S. nonprofit institutions. Recent grants ranged from $25,000 to $825,000, with a median of about $201,000; applications are submitted through specified award mechanisms, and the profile does not state whether unsolicited requests are accepted.
Assets
$225.7M
Grants
51
Total Given
$13.5M
The Susan G Komen Breast Cancer Foundation Inc
Dallas, TX
The Susan G. Komen Breast Cancer Foundation funds breast cancer research and programs supporting education, patient navigation, financial assistance, and access to care. Its 2025 grants ranged from $2,681 to $945,992, with a median of $158,660, and it funds work in the United States and 24 other countries. Research applications require an LOI, and full applications are by invitation; whether it accepts unsolicited requests is not stated.
Assets
$178.9M
Grants
61
Total Given
$16.1M
The Breast Cancer Research Foundation Inc
New York, NY
The Breast Cancer Research Foundation funds worldwide research to prevent and cure breast cancer, supporting scientists and projects at academic and medical institutions. Its 2025 grants had a median of $450,000, though awards varied widely; it discourages unsolicited funding requests and invites proposals through its Scientific Advisory Board.
Assets
$220.5M
Grants
76
Total Given
$61.1M
Fred Hutchinson Cancer Center
Seatle, WA
Fred Hutchinson Cancer Center funds cancer and infectious disease research, along with Washington community-led projects in cancer prevention, screening, education, and care access. Research grants vary widely (the 2025 median was about $118,000); its community awards were up to $15,000, and Tribal Community Grants up to $50,000 plus indirect costs. Community programs are focused on Washington State; whether unsolicited requests are accepted is not stated.
Assets
$3.6B
Grants
139
Total Given
$88.2M
The Children's Hospital of Philadelphia
Philadelphia, PA
CHOP primarily funds pediatric research at universities, hospitals, and research organizations, and also supports employee-led health projects in communities served by CHOP and its Care Network in Pennsylvania and New Jersey. In 2025, it awarded 138 grants totaling about $50.3 million; the median grant was about $115,000, with awards ranging from about $5,800 to $14 million. The profile does not state whether CHOP accepts unsolicited requests.
Assets
$9.1B
Grants
138
Total Given
$50.3M
Vanderbilt University Medical Center
Nashville, TN
Vanderbilt University Medical Center supports medical and scientific research, health and educational programs, and related institutional purposes, with grants to universities, medical centers, and research organizations. Its 2025 grants had a median of about $116,000, though awards ranged widely; recipients were based across the U.S., with the most funding going to Tennessee. The profile does not state whether it accepts unsolicited requests.
Assets
$7.8B
Grants
246
Total Given
$125.1M
More similar funders
More Funders in Pennsylvania
Cite this profile
Grantable. (2026). National Comprehensive Cancer Network funder profile. GrantGraph. Retrieved October 19, 2026, from https://grantable.co/funders/national-comprehensive-cancer-network-morg_f7d296bd3dc448baa8cde73ac4fb935d
BibTeX
@misc{grantable_232818395_2026,
author = {{Grantable}},
title = {{National Comprehensive Cancer Network funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/national-comprehensive-cancer-network-morg_f7d296bd3dc448baa8cde73ac4fb935d},
note = {Accessed 2026-10-19. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from National Comprehensive Cancer Network's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
National Comprehensive Cancer Network down — hundreds of funders to go?